Expression and Significances of Contactin-1 in Human Gastric Cancer

Table 5

Relationship between LVD and other clinicopathological features.

Clinicopathological features	Total cases	LVD (mean ± SD)	P value
Age (ys)
≧60	69	10.94 ± 8.27	0.261
<60	36	8.97 ± 8.79
Gender
Male	73	9.71 ± 8.25	0.314
Female	32	11.52 ± 8.92
Tumor size
≧5 cm	58	11.05 ± 8.35	0.291
<5	47	9.29 ± 8.59
Tumor location
Upper	17	11.62 ± 7.64	0.435
Middle	34	8.78 ± 8.41
Lower	54	10.77 ± 8.75
Lauren’s classification
Intestinal	70	10.21 ± 8.51	0.934
Diffuse	35	10.36 ± 8.49
TNM stage
I + II	41	7.41 ± 9.08	0.008
III + IV	64	12.09 ± 7.56
Vascular invasion
(+)	26	13.92 ± 6.70	0.004
(−)	79	9.06 ± 8.67
Serosa invasion
(+)	37	11.5 ± 7.82	0.257
(−)	68	9.59 ± 8.77
Lymphatic invasion
(+)	66	12.83 ± 7.46	<0.001
(−)	39	5.92 ± 8.37
Lymph node metastasis
(+)	70	12.20 ± 7.87	0.001
(−)	35	6.39 ± 8.37
Lymph node metastatic ratio
≧20%	51	13.40 ± 7.63	<0.001
<20%	54	7.30 ± 8.19
VEGF-C
(+)	59	12.63 ± 7.41	0.001
(−)	46	7.23 ± 8.34
VEGFR-3
(+)	68	13.11 ± 7.01	0.011
(−)	37	9.12 ± 8.13
CNTN-1
(+)	61	12.80 ± 7.95	<0.001
(−)	44	6.75 ± 7.96